A detailed history of Verition Fund Management LLC transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Verition Fund Management LLC holds 34,015 shares of HBIO stock, worth $73,472. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34,015
Previous 38,310 11.21%
Holding current value
$73,472
Previous $109,000 16.51%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.64 - $3.54 $11,338 - $15,204
-4,295 Reduced 11.21%
34,015 $91,000
Q2 2024

Aug 14, 2024

BUY
$2.77 - $4.63 $106,118 - $177,375
38,310 New
38,310 $109,000
Q2 2023

Aug 14, 2023

BUY
$4.19 - $6.16 $106,459 - $156,513
25,408 New
25,408 $139,000

Others Institutions Holding HBIO

About HARVARD BIOSCIENCE INC


  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $89.9M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.